Possible serotonin syndrome arising from an interaction between nortriptyline and selegiline in a lady with parkinsonism.
Hinds
N P
NP
Hillier
C E
CE
Wiles
C M
CM
D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects*; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D009661:Nortriptyline / Q000008:administration & dosage / Q000009:adverse effects*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*; D020230:Serotonin Syndrome / Q000139:chemically induced*
D000929:Antidepressive Agents, Tricyclic; D000978:Antiparkinson Agents; D012642:Selegiline; D009661:Nortriptyline